RRM2 and breast cancer: In addition, previous studies have pointed out that high expression of RRM2 may promote chemotherapy resistance in breast cancer patients [36, 37]; thus, in Luminal breast cancer, high expression of RRM2 may influence the OS of patients by promoting drug resistance.